{"nctId":"NCT00335283","briefTitle":"Efficacy of Lansoprazole in Chronic Post Nasal Drip","startDateStruct":{"date":"2006-08"},"conditions":["Larynx Disease"],"count":75,"armGroups":[{"label":"Lansoprazole","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Lansoprazole Tablet","Procedure: PH and impedence testing","Procedure: manometry","Drug: lansoprazole"]},{"label":"Sugar Pill","type":"PLACEBO_COMPARATOR","interventionNames":["Procedure: PH and impedence testing","Procedure: manometry","Drug: placebo"]}],"interventions":[{"name":"Lansoprazole Tablet","otherNames":["prevacid"]},{"name":"PH and impedence testing","otherNames":[]},{"name":"manometry","otherNames":[]},{"name":"lansoprazole","otherNames":[]},{"name":"placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Negative RAST inhalant allergy panel OR negative skin testing (Group A)\n* Positive RAST or Positive skin testing AND insufficient response to all of the following: (Group B)\n\n  * Allergen avoidance\n  * Topical nasal steroids\n  * Allergy shots if indicated\n  * Antihistamines\n  * Negative CT sinuses (coronal)\n  * \\< 4mm of mucosal thickening and \\< 3 sinus sites\n  * Absence of air-fluid levels\n  * Negative anterior rhinoscopy\n  * Absence of pus, crusts on mucosal surfaces\n\nExclusion Criteria:\n\n* Age \\< 18\n* Pregnancy, confirmed by urine pregnancy test at day of randomization\n* Ciliary dyskinesia\n* Immune deficiency\n* Cystic fibrosis\n* Diagnosis of acute sinusitis or chronic RS (AAO-HNS)\n* Active use of topical decongestant\n* Use of PPI within the last 30 days\n* Previous fundoplication\n* Uncontrolled thyroid disease\n* Isolated chronic cough without the symptom of post nasal drip","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Post Nasal Drainage Symptom Response","description":"The primary outcome measure was postnasal drainage symptom response measured by using a visual analogue scale. At 8 and 16 weeks, a horizontal symptoms scale from 0% (no change) to 100% (symptoms completely resolved) was presented to participants to assess improvement in postnasal drainage symptoms.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"55","spread":null},{"groupId":"OG001","value":"3.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"50","spread":null},{"groupId":"OG001","value":"5","spread":null}]}]}]},{"type":"SECONDARY","title":"Rhinosinusitis Outcome Measure(RSOM-31)","description":"RSOM-31 includes 31 questions combined into a total score ranging from 0 to 155 with higher scores representing greater disease burden. Values are based on patient report.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"63","spread":null},{"groupId":"OG001","value":"51","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"40","spread":null},{"groupId":"OG001","value":"36","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"35","spread":null},{"groupId":"OG001","value":"35","spread":null}]}]}]},{"type":"SECONDARY","title":"Sino Nasal Outcome Test (SNOT-20)","description":"SNOT-20 includes 20 questions combined into a total score ranging from 0 to 100 with higher numbers representing greater rhinosinusitis health burden and represents patient-reported symptom severity.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"36","spread":null},{"groupId":"OG001","value":"35","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"25","spread":null},{"groupId":"OG001","value":"32","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"20","spread":null},{"groupId":"OG001","value":"27","spread":null}]}]}]},{"type":"SECONDARY","title":"Quality of Life Questionnaire (QOLRAD)","description":"The patient-reported QOLRAD consists of 25 questions combined into a total score ranging from 25 to 175 with higher numbers representing better quality of life.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"155","spread":null},{"groupId":"OG001","value":"160","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"174","spread":null},{"groupId":"OG001","value":"155","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"173","spread":null},{"groupId":"OG001","value":"160","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":36},"commonTop":[]}}}